Physician profile
Matthew Allen Sample
NPI 1871736637
$16,776.20
in general payments reported to CMS, 2019-2025
23 companies · $2,331 in 2025
The $2,331 reported for 2025 was more than what 86% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $981 · 2020: $5,798 · 2021: $966 · 2022: $719 · 2023: $1,790 · 2024: $4,192 · 2025: $2,331.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,919 · Travel and Lodging: $2,394.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,918.91 |
| Travel and Lodging | $2,393.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $10,843.09 | 2019-2025 | Mitraclip, Triclip, Amplatzer |
| Edwards Lifesciences Corporation | $2,258.69 | 2019-2025 | Sapien 3 Ultra Resilia, Pascal, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Medtronic, INC. | $664.65 | 2022-2025 | Onyx Frontier, Abre, Symplicity G3 |
| Inari Medical, INC. | $622.90 | 2019-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Philips North America LLC | $530.02 | 2019-2025 | Ice 3d |
| Shockwave Medical, INC | $393.44 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boston Scientific Corporation | $321.42 | 2023-2024 | Eluvia |
| W. L. Gore & Associates, INC. | $254.46 | 2019-2021 | |
| Cvrx, INC. | $182.85 | 2021-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $145.47 | 2020-2025 | Lifevest |
| Angiodynamics, INC. | $93.67 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $85.85 | 2023-2025 | Xifaxan |
| Celonova Biosciences, INC. | $65.52 | 2019 | |
| Terumo Medical Corporation | $61.77 | 2021 | |
| Siemens Medical Solutions USA, INC. | $49.42 | 2022-2024 | Naeotom Alpha |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiva Medical, INC. | $38.77 | 2024 | Cardiva Vascade 6/7f Vcs, Savvywire |
| Ge Healthcare | $32.32 | 2023 | |
| Stryker Corporation | $30.16 | 2025 | Artix Mt |
| Atricure, INC. | $25.52 | 2024 | |
| Novartis Pharmaceuticals Corporation | $23.08 | 2021 | |
| Livanova USA, INC. | $19.90 | 2023 | Tandemlife |
| Esperion Therapeutics, INC. | $18.99 | 2021 | |
| Janssen Pharmaceuticals, INC | $14.24 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Sample listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.